J9275
HCPCSInj cosibelimab-ipdl, 2 mg
Official HCPCS Level II long descriptor
Injection, cosibelimab-ipdl, 2 mg
HCPCS Level II code J9275 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj cosibelimab-ipdl, 2 mg
Added to HCPCS: 2025-07-01
Nearby codes in J9
- J9266Pegaspargase injection
- J9267Paclitaxel injection
- J9268Pentostatin injection
- J9269Inj. tagraxofusp-erzs 10 mcg
- J9271Inj pembrolizumab
- J9272Inj, dostarlimab-gxly, 10 mg
- J9273Inj tisotu vedotin-tftv, 1mg
- J9274Inj, tebentafusp-tebn, 1 mcg
- J9276Inj zanidatamab-hrii, 2 mg
- J9277Pembrolizumab 1mg berahyalur
- J9278Inj, carboplatin (avyxa)
- J9280Mitomycin injection
- J9281Mitomycin instillation
- J9282Mitomycin intravesical inst
- J9285Inj, olaratumab, 10 mg
- J9286Inj glofitamab gxbm, 2.5 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.